Innatoss Laboratories

Innatoss Laboratories is a Dutch biotechnology company founded in 2012 with a focus on developing and performing in vitro diagnostics of infectious diseases such as Lyme disease, Q fever, and more recently, COVID-19. Positioned at the center of the largest Q fever epidemic, the organization is passionately dedicated to advancing diagnostics to detect these diseases at their earliest stages, aiming to alleviate associated health problems. Their recent achievements include obtaining a CE certification for the first cell-mediated immunity test for Q fever (Q-detect), membership in a Q fever vaccine development program led by Massachusetts General Hospital, and securing an EU Horizon 2020 grant for the development of a cellular Lyme diagnostic test. The company actively seeks new opportunities, collaborations, and advancements in diagnostic testing for infectious diseases to further their mission. Innatoss Laboratories operates within the Biotechnology and Health Care industries, offering expertise as a laboratory for infectious disease assay development.